Purification of ribonucleotide reductase subunits Y1, Y2, Y3, and Y4 from yeast: Y4 plays a key role in diiron cluster assembly

被引:40
|
作者
Nguyen, HHT [1 ]
Ge, J [1 ]
Perlstein, DL [1 ]
Stubbe, J [1 ]
机构
[1] MIT, Dept Biol & Chem, Cambridge, MA 02139 USA
关键词
D O I
10.1073/pnas.96.22.12339
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ribonucleotide reductases (RNRs) catalyze the conversion of nucleotides to deoxynucleotides. Class I RNRs are composed of two types of subunits: RNR1 contains the active site for reduction and the binding sites for the nucleotide allosteric: effecters. RNR2 contains the diiron-tyrosyl radical (Y .) cofactor essential for the reduction process. Studies in yeast have recently identified four RNR subunits: Y1 and Y3, Y2 and Y4. These proteins have been expressed in Saccharomyces cerevisiae and in Escherichia coli and purified to approximate to 90% homogeneity. The specific activity of Y1 isolated from yeast and E. coli is 0.03 mu mol.min(-1).mg(-1) and of (His)(6)-Y2 [(His)(6)-Y2-K387N] from yeast is 0.037 mu mol.min(-1).mg(-1) (0.125 mu mol.min(-1.)mg(-1)). Y2, Y3, and Y4 isolated from E. coli have no measurable activity. Efforts to generate Y . in Y2 or Y4 using Fe2+, O-2 and reductant have been unsuccessful. However, preliminary studies show that incubation of Y4 and Fe2+ with inactive E. coli Y2 followed by addition of O-2 generates Y2 with a specific activity of 0.069 mu mol.min(-1.)mg(-1) and a Y .. A similar experiment with (His)(6)-Y2-K387N, Y4, O-2, and Fe2+ results in an increase in its specific activity to 0.30 mu mol.min(-1).mg(-1). Studies with antibodies to Y4 and Y2 reveal that they can form a complex in vivo. Y4 appears to play an important role in diiron-Y . assembly of Y2.
引用
收藏
页码:12339 / 12344
页数:6
相关论文
共 50 条
  • [21] Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice
    Wultsch, T
    Painsipp, E
    Donner, S
    Sperk, G
    Herzog, H
    Peskar, BA
    Holzer, P
    BEHAVIOURAL BRAIN RESEARCH, 2006, 168 (02) : 255 - 260
  • [22] Functional reconstitution of human neuropeptide Y (NPY) Y2 and Y4 receptors in Sf9 insect cells
    Pop, Nathalie
    Igel, Patrick
    Brennauer, Albert
    Cabrele, Chiara
    Bernhardt, Guenther
    Seifert, Roland
    Buschauer, Armin
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2011, 31 (04) : 271 - 285
  • [23] Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors
    Alvaro, Ana Rita
    Rosmaninho-Salgado, Joana
    Ambrosio, Antonio F.
    Cavadas, Claudia
    JOURNAL OF NEUROCHEMISTRY, 2009, 109 (05) : 1508 - 1515
  • [24] Differential implications of neuropeptide Y, peptide YY, Y2 an Y4 receptors in circadian homecage/explorative activitiy and ingestive behaviour
    Edelsbrunner, M.
    Holzer, P.
    Herzog, H.
    Sperk, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 229 - 229
  • [25] Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist analogues: Implications for selectivity
    Jois, SDS
    Nagarajarao, LM
    Prabhakaran, M
    Balasubramaniam, A
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2006, 23 (05): : 497 - 508
  • [26] Hammerhead ribozymes that selectively cleave the NPY Y1, Y4, and Y5 receptor full-length RNA
    Wieland, HA
    Hamilton, BS
    Krist, B
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (05): : 435 - 440
  • [27] Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors
    Wultsch, T
    Painsipp, E
    Thoeringer, CK
    Herzog, H
    Sperk, G
    Holzer, P
    NEUROSCIENCE, 2005, 136 (04) : 1097 - 1107
  • [28] Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice
    Sainsbury, A
    Baldock, PA
    Schwarzer, C
    Ueno, N
    Enriquez, RF
    Couzens, M
    Inui, A
    Herzog, H
    Gardiner, EM
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (15) : 5225 - 5233
  • [29] Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male rat
    Raposinho, PD
    Broqua, P
    Hayward, A
    Akinsanya, K
    Galyean, R
    Schteingart, C
    Junien, JL
    Aubert, ML
    NEUROENDOCRINOLOGY, 2000, 71 (01) : 2 - 7
  • [30] Pharmacological characterization of 125I-1229U91 binding to Y1 and Y4 neuropeptide Y/peptide YY receptors
    Schober, DA
    Gackenheimer, SL
    Heiman, ML
    Gehlert, DR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 293 (01): : 275 - 280